Nivolumab (gastro-oesophageal cancers): Injection concentrate for I.V. infusion 40 mg in 4 mL, Injection concentrate for I.V. infusion 100 mg in 10 mL; Opdivo® Page last updated: 30 June 2023 Public Summary Document (PSD) March 2023 PBAC Meeting - (PDF 431KB) Public Summary Document (PSD) March 2023 PBAC Meeting - (Word 80KB)